IMMIX BIOPHARMA INC's ticker is and the CUSIP is 45258H106. A total of 19 filers reported holding IMMIX BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $146,923 | +27.1% | 42,960 | 0.0% | 0.00% | – |
| Q2 2023 | $115,562 | +47.8% | 42,960 | 0.0% | 0.00% | – |
| Q1 2023 | $78,187 | -60.3% | 42,960 | -50.0% | 0.00% | – |
| Q4 2022 | $196,756 | +239.2% | 85,920 | +100.0% | 0.00% | – |
| Q3 2022 | $58,000 | -42.0% | 42,960 | +11.4% | 0.00% | – |
| Q2 2022 | $100,000 | – | 38,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 25,000 | $58 | 0.07% |
| Moss Adams Wealth Advisors LLC | 20,000 | $45,800 | 0.02% |
| Murchinson Ltd. | 67,200 | $153,888 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 33,600 | $76,944 | 0.00% |
| InterOcean Capital Group, LLC | 15,900 | $36,411 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 12,597 | $28,847 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 10 | $22 | 0.00% |
| WELLS FARGO & COMPANY/MN | 37 | $85 | 0.00% |
| NORTHERN TRUST CORP | 19,151 | $43,856 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |